Clinical Trials Directory

Trials / Completed

CompletedNCT01551199

Exposure Therapy for Veterans With PTSD and Panic Attacks (Phase 1)

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
7 (actual)
Sponsor
VA Office of Research and Development · Federal
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Not accepted

Summary

To evaluate the feasibility, acceptability and effectiveness of Multiple Channel Exposure Therapy-Veterans (MCET-V) as a treatment for returning service members with comorbid posttraumatic stress disorder (PTSD) and panic disorder (PD) in two phases. The first phase of the study will examine the feasibility and acceptability of MCET-V.

Detailed description

With the increasing number of Operations Iraqi Freedom and Enduring Freedom (OIF/OEF) veterans returning from war-zone areas, many will experience anxiety disorders such as PTSD and comorbid problems. Currently, about one in every six OIF/OEF veterans experiences PTSD and co-occurring PD. Although effective treatments exist for treating one or the other, we do not yet have treatments that can simultaneously target PTSD and PD. Thus, recent attention has focused on the development of multi-component treatments that simultaneously address PTSD and PD. This study is the first systematic investigation of a time-limited, multi-component cognitive-behavioral treatment for veterans with specific comorbid anxiety problems. The purpose of the first phase of the study is to evaluate the feasibility and acceptability of the multi-component cognitive-behavioral treatment in an open trial.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMultiple Channel Exposure Therapy- VeteransIndividual therapy design completed over a 12-week period. The treatment will include psychoeducation about panic attacks and trauma and behavioral and cognitive exposure exercises.

Timeline

Start date
2012-03-01
Primary completion
2013-02-01
Completion
2013-06-01
First posted
2012-03-12
Last updated
2017-02-23
Results posted
2015-01-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01551199. Inclusion in this directory is not an endorsement.